Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
about
Opioid prescriptions for chronic pain and overdose: a cohort studySubjective assessments of comorbidity correlate with quality of life health outcomes: initial validation of a comorbidity assessment instrument.The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population LevelRefined comorbidity index based on dimensionality of comorbidity for use in studies of health-related quality of life.Performance of comorbidity, risk adjustment, and functional status measures in expenditure prediction for patients with diabetes.Depression and advanced complications of diabetes: a prospective cohort study.Depression and incident diabetic foot ulcers: a prospective cohort study.Cost of breast-related care in the year following false positive screening mammograms.Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study.Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications.Using highly detailed administrative data to predict pneumonia mortality.Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapyPerformance of in-hospital mortality prediction models for acute hospitalization: hospital standardized mortality ratio in JapanPharmacy data in the VA health care system.The association of comorbidities, utilization and costs for patients identified with low back pain.Validation of a method for identifying nursing home admissions using administrative claims.Seniors' self-reported multimorbidity captured biopsychosocial factors not incorporated into two other data-based morbidity measures.The relationship between effectiveness and costs measured by a risk-adjusted case-mix system: multicentre study of Catalonian population data bases.An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in TaiwanApplying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibrationHow does change in depressive symptomatology influence weight change in patients with diabetes? Observational results from the Pathways longitudinal cohort.Comparison of Rx-defined morbidity groups and diagnosis- based risk adjusters for predicting healthcare costs in Taiwan.Health effects of parental deaths among adults in Norway: Purchases of prescription medicine before and after bereavement.Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?Relationship styles and mortality in patients with diabetes.Breast and cervical cancer screening specific effects of depression and obesity.Relationship of opioid use and dosage levels to fractures in older chronic pain patientsComorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study.Cross-sectional study of periodontal care and Glycosylated Hemoglobin in an insured population.Evaluating a preventive services index to adjust for healthy behaviors in observational studies of older adults.Comorbidity in aging and dementia: scales differ, and the difference matters.Evaluating components of dental care utilization among adults with diabetes and matched controls via hurdle models.Case-mix adjusting performance measures in a veteran population: pharmacy- and diagnosis-based approaches.Risk segmentation related to the offering of a consumer-directed health plan: a case study of Humana Inc.Implementing group medical visits for older adults at group health cooperativeDisease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparisonAssociation of living alone and hospitalization among community-dwelling elders with and without dementia.Healthcare cost differences with participation in a community-based group physical activity benefit for medicare managed care health plan members.Evaluation of a drug-drug interaction: fax alert intervention program.Quality of preventive care for diabetes: effects of visit frequency and competing demands.
P2860
Q24630037-F0BC3F90-FF50-4414-B108-C48D71618416Q24813902-BEED6D5D-D2D3-4B44-9D01-114E3049D537Q28550269-26B779C5-E954-49EC-8C60-CD27CBA2FC72Q30276875-0EDF9D66-36D6-45AA-8FAC-A85218AE61E8Q30485139-56252267-87C1-4A17-8211-3533C08CE773Q30492851-3DDB1850-57BC-4B75-8458-12BC9136C4EEQ30495804-02739790-7B88-4F19-B46E-562570522D7EQ30499746-3331F565-E54B-4583-99C0-6515A37E6BBCQ30541872-C5FEE80F-B9AD-4125-AD4F-19B9EE88C7CBQ30686074-01DE44BD-C2C3-44DE-9980-7663D7B6BDB7Q30749143-F9AF7242-001F-4651-BF2F-D7DEE4BD9BBFQ30850706-61821DAB-2894-4E26-8EA8-14329C9BC552Q30850759-99BF2B3B-CF78-4EC6-AA6B-C4C3C95CDDE2Q30923267-C35E4457-CA01-4780-A7B2-2E8C2879702EQ33257904-ADD12802-36E1-4BA0-9093-52B6895BC714Q33309498-45EEF84F-3EEB-4D5A-8863-8751B09F84E1Q33364813-70CEF711-1258-4627-801E-6ECF4B305865Q33474559-0C49F453-0F2A-4668-9362-E2F60711E50BQ33524889-C66E9F22-4DD4-42B6-B657-76C0A200F732Q33525713-A89CF5D7-64C6-4F6A-8C6E-5DF7415C49D0Q33552119-EED1A518-E989-4129-9724-CACEBBF839D7Q33579539-85DA3EF1-615D-40D4-BA44-E5467F416C33Q33600536-2ADF3F7E-0C73-45CD-B1EC-3BE4B709DB50Q33606011-E58C1DFC-17E1-4E0E-9CD0-8C0A6EC5C3C0Q33683664-25A8A8C7-8D43-4398-9290-28CCA72BBABDQ33715227-60E1D5DE-98B5-406B-BE7E-D846AD2FB05AQ33742530-52B9B5E3-E3CF-4143-8489-3A34BF579024Q33791007-032F979C-0EEC-4056-AE20-08BBE2DA6020Q34016005-AF0AD591-CB89-42FD-AD66-91292C1BF3EDQ34123511-F86684FA-CA50-43DE-ADA1-DECAA0B7B8E3Q34233250-AC03F7E6-09CA-4AC3-B31A-EEFD09611C84Q34331230-437E3228-10AF-4E72-97FE-26B5AF781C78Q34336060-8BDF56B0-CFDF-4163-8FE9-4750122A4179Q34336694-1B19724A-3E53-445A-AE55-051BE5C848CEQ34420346-F0D386ED-ED20-4230-8541-C5B114234FD8Q34493849-3B62BA28-EED6-476B-AE7E-6FA082604456Q34546478-6F5CA3FB-91BC-43FD-B3B8-FA78FFB1ED7AQ34565811-BF586079-9333-4512-9CBB-4DB5D4EE53B6Q34623440-837E4311-9036-4588-B9B4-E3B5A1DC5810Q34629772-7B9BF5A4-0905-4054-9AC6-4A256BA40381
P2860
Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
@ast
Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
@en
type
label
Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
@ast
Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
@en
prefLabel
Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
@ast
Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
@en
P2093
P1433
P1476
Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
@en
P2093
Donald J Bachman
Mark C Hornbrook
Maureen C O'Keeffe Rosetti
Michael J Goodman
Paul A Fishman
Richard T Meenan
P356
10.1097/00005650-200301000-00011
P577
2003-01-01T00:00:00Z